1. Home page
  2. Search

Lipid-lowering effect and safety of acipimox in hemodialysis patients and renal transplant recipients

This item is provided by the institution :
/aggregator-openarchives/portal/institutions/uoa   

Repository :
Πέργαμος   

see the original item page
in the repository's web site and access all digital files if the item*



Lipid-lowering effect and safety of acipimox in hemodialysis patients and renal transplant recipients
Tzanatos, H. Koutsikos, D. Agroyannis, B. Kapetanaki, A. Tsoutsos, D. Konstadinidou, I. Chondros, K. Exarchos, D.
scientific_publication_article
Επιστημονική δημοσίευση - Άρθρο Περιοδικού (EL)
Scientific publication - Journal Article (EN)
1994
The efficacy and safety of acipimox, an antilipolytic agent, were studied in 10 uremic patients under hemodialysis (group A) and in 8 renal transplant recipients with adequate renal function (group B). The medication was given for 20 weeks at a dose of 250 mg daily in both groups. Total serum cholesterol decreased significantly from 218.1 ± 17.4 to 175.2 ± 15.2 mg/dL (-19.7% in group A and from 261.2 ± 16.5 to 215.3 ± 26.9 mg/dL (-17.6% in group B; as did serum triglycerides, from 206.7 ± 26.9 to 146.9 ± 17.6 mg/dL (-29% in group A and from 168.2 ± 20.6 to 111.3 ± 12.4 mg/dL (-33.8% in group B. Low-density lipoprotein (LDL)-cholesterol and very low-density lipoprotein (VLDL)-cholesterol were also decreased significantly (LDL-C by -27% and -25% and VLDL-C by -29.2% and -33.8% in groups A and B, respectively). Furthermore, the high-density lipoprotein (HDL)-cholesterol was increased significantly, by +29.6% in group A and + 18% in group B. The apolipoproteins Apo-A1 and Apo-A2 were decreased in Group A but not in group B. The Apo-B was decreased in group B. Serum CPK (total and muscle fraction), total bilirubin, SGPT, SGOT, alkuline phosphatase, γGT, LDL, a-Fp, and creatinine remained unchanged in both groups. Acipimox seems to be effective in the regulation of atherogenic lipid disorders in hemodialysis patients and renal transplant recipients, without any muscular damage or alteration of kidney and liver function. © 1994 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted. (EN)
English
Ερευνητικό υλικό ΕΚΠΑ
https://creativecommons.org/licenses/by-nc/4.0/
Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών
Πέργαμος
Journal Article



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)